Table 1 Socio-demographic and clinical characteristics of study participants

Age in years

18-29

83

25.7

30-39

137

42.4

≥ 40

103

31.9

Sex

Male

119

36.8

Female

204

63.2

Participant address

Kampala

211

65.3

Wakiso

86

26.6

Others

26

8

Marital status

Married

184

48.8

Unmarried

193

51.2

Treatment Line (n=282)

First line

143

50.7

 s line

139

49.3

Who clinical stage at time of VL non-suppression (n=266)

Stage 1

253

95.1

Stage 2

6

2.3

Stage 3

3

1.1

Stage 4

4

1.5

Duration on ART at Viral Load non-suppression (n=320)

< 1 year

64

20

> 1 to 5 years

103

32.2

> 5 years

153

47.8

Non-suppressed viral load test results (Copies/ml)

1,000-4,999

148

45.8

5,000-10,000

35

10.8

≥ 10,000

140

43.3

ART regimen at time of VL non-suppression

EFV based regimen

143

44.3

NVP based regimen

61

18.9

ATV/r based regimen

36

11.1

DTG based regimen

64

19.8

LPV/r based regimen

19

5.9